CHMP officially recommends Bavarian Nordic's vaccine for monkeypox in Europe
Bavarian Nordic’s vaccine was already approved in the monkeypox indication in the US and Canada – Imvanex is now one step closer to gaining the same authorization in Europe.
by marketwire, translated by daniel pedersen
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted Bavarian Nordic a positive opinion to extend smallpox vaccine Imvanex’s indication to include monkeypox, the firm reported Friday.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
.jpg)
.jpg&w=384&q=75)
